Start
Entdecken
nav.journalClub
Trends
Mehr
synapse
⌘+K
Sprache
Deutsch
Deutsch
Combination of HGF/IL-22 mRNAs delivered by GalNAc-lipid nanoparticles to treat acute liver injury | Synapse
March 3, 2026
Combination of HGF/IL-22 mRNAs delivered by GalNAc-lipid nanoparticles to treat acute liver injury
JL
Jianhong Luo
YJ
Yuhao Jiang
XY
Xudong Yin
See all
Key Points
HGF and IL-22 mRNAs delivered via nanoparticles improved recovery in liver injury models, indicating promising therapeutic potential.
Key metrics include significant reduction in liver injury markers and enhanced repair processes following treatment.
Assessment used a novel delivery system involving GalNAc-lipid nanoparticles to efficiently target liver cells for mRNA delivery.
Results support the need for further exploration into mRNA-based therapies for liver injury, highlighting potential in clinical applications.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Luo et al. (Sat,) studied this question.
synapsesocial.com/papers/69a76140c6e9836116a2f036
https://doi.org/https://doi.org/10.1016/j.ijpharm.2026.126679